Showing content from https://patents.google.com/patent/GB1413070A/en below:
GB1413070A - Process for the production of - norfenfluramine and - fenfluramine and salts thereof
GB1413070A - Process for the production of - norfenfluramine and - fenfluramine and salts thereof - Google PatentsProcess for the production of - norfenfluramine and - fenfluramine and salts thereof Info
-
Publication number
-
GB1413070A
GB1413070A GB3592373A GB3592373A GB1413070A GB 1413070 A GB1413070 A GB 1413070A GB 3592373 A GB3592373 A GB 3592373A GB 3592373 A GB3592373 A GB 3592373A GB 1413070 A GB1413070 A GB 1413070A
-
Authority
-
GB
-
United Kingdom
-
Prior art keywords
-
norfenfluramine
-
prepared
-
group
-
salt
-
formula
-
Prior art date
-
1973-07-27
-
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
-
Expired
Application number
GB3592373A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1973-07-27
Filing date
1973-07-27
Publication date
1975-11-05
1973-07-27 Application filed by Beecham Group PLC filed Critical Beecham Group PLC
1973-07-27 Priority to GB3592373A priority Critical patent/GB1413070A/en
1975-11-05 Publication of GB1413070A publication Critical patent/GB1413070A/en
Status Expired legal-status Critical Current
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- 229960001582 fenfluramine Drugs 0.000 title 1
- MLBHFBKZUPLWBD-SSDOTTSWSA-N (2R)-1-[3-(trifluoromethyl)phenyl]-2-propanamine Chemical compound C[C@@H](N)CC1=CC=CC(C(F)(F)F)=C1 MLBHFBKZUPLWBD-SSDOTTSWSA-N 0.000 abstract 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- RQEUFEKYXDPUSK-UHFFFAOYSA-N 1-phenylethylamine Chemical compound CC(N)C1=CC=CC=C1 RQEUFEKYXDPUSK-UHFFFAOYSA-N 0.000 abstract 1
- DBGIVFWFUFKIQN-SECBINFHSA-N Levofenfluramine Chemical compound CCN[C@H](C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-SECBINFHSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
- C07C209/52—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of imines or imino-ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1413070 (-)-Norfenfluramine BEECHAM GROUP Ltd 18 July 1974 [27 July 1973] 35923/73 Heading C2C (-)-Norfenfluramine or a salt thereof may be prepared by hydrogenating the novel compound of Formula (I) or a salt thereof: where R is a phenyl group, optionally substituted in the meta- or para-positions by a non- reactive group that does not interfere with the hydrogenation, the carbon atom marked with one asterisk has the same configuration as (-)-norfenfluramine and the carbon atom marked with two asterisks has the configuration found in (+ )-a-methylbenzylamine. The compound of Formula (I) may be prepared by reducing a compound of Formula II or a salt thereof: which may itself be prepared by reacting l-(mtrifluoromethylphenyl)propan-2-one with (+ )- α-methylbenzylamine. (-)-Fenfluramine may be prepared by the acetylation of (-)-norfenfluramine in conventional manner followed by reduction of the acetyl group to an ethyl group.
GB3592373A 1973-07-27 1973-07-27 Process for the production of - norfenfluramine and - fenfluramine and salts thereof Expired GB1413070A (en) Priority Applications (1) Application Number Priority Date Filing Date Title GB3592373A GB1413070A (en) 1973-07-27 1973-07-27 Process for the production of - norfenfluramine and - fenfluramine and salts thereof Applications Claiming Priority (1) Application Number Priority Date Filing Date Title GB3592373A GB1413070A (en) 1973-07-27 1973-07-27 Process for the production of - norfenfluramine and - fenfluramine and salts thereof Publications (1) Publication Number Publication Date GB1413070A true GB1413070A (en) 1975-11-05 Family ID=10383048 Family Applications (1) Application Number Title Priority Date Filing Date GB3592373A Expired GB1413070A (en) 1973-07-27 1973-07-27 Process for the production of - norfenfluramine and - fenfluramine and salts thereof Country Status (1) Cited By (15) * Cited by examiner, â Cited by third party Publication number Priority date Publication date Assignee Title EP0875498A3 (en) * 1997-04-28 2000-07-26 Alfa Chemicals Italiana S.r.l. Process for the production of the isomers (R) and (S)-Alpha-methyl-3-(trifluoromethyl)benzeneethanamine WO2014177676A1 (en) 2013-05-03 2014-11-06 Katholieke Universiteit Leuven Fenfluramine for use in the treatment of dravet syndrome WO2018206924A1 (en) 2017-05-09 2018-11-15 Zogenix International Limited Methods of treating doose syndrome using fenfluramine WO2019067419A1 (en) 2017-09-26 2019-04-04 Zogenix International Limited Improvement in cognitive function with fenfluramine WO2019067405A2 (en) 2017-09-26 2019-04-04 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation WO2019067413A1 (en) 2017-09-26 2019-04-04 Zogenix International Limited Use of fenfluramine formulation in reducing number and frequencies of convulsive seizures in patient populations WO2020014075A1 (en) 2018-07-10 2020-01-16 Zogenix International Limited Fenfluramine for use for treating epilepsy or epileptic encephalopathy in patients without pulmonary hypertension WO2020105005A1 (en) 2018-11-19 2020-05-28 Zogenix International Limited Methods of treating rett syndrome using fenfluramine WO2021053389A1 (en) 2019-09-17 2021-03-25 Zogenix International Limited Methods of treating epileptic patients with fenfluramine WO2021156437A1 (en) 2020-02-05 2021-08-12 Zogenix International Limited Fenfluramine for use in treating patients with lennox-gastaut syndrome WO2022013425A1 (en) 2020-07-17 2022-01-20 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) US11634377B2 (en) 2015-12-22 2023-04-25 Zogenix International Limited Fenfluramine compositions and methods of preparing the same US11673852B2 (en) 2015-12-22 2023-06-13 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same US11759440B2 (en) 2016-08-24 2023-09-19 Zogenix International Limited Formulation for inhibiting formation of 5-HT2B agonists and methods of using same EP4397372A2 (en) 2015-08-24 2024-07-10 Zogenix International Limited Methods of treating lennox-gastaut syndrome using fenfluramine
Cited By (20) * Cited by examiner, â Cited by third party Publication number Priority date Publication date Assignee Title EP0875498A3 (en) * 1997-04-28 2000-07-26 Alfa Chemicals Italiana S.r.l. Process for the production of the isomers (R) and (S)-Alpha-methyl-3-(trifluoromethyl)benzeneethanamine WO2014177676A1 (en) 2013-05-03 2014-11-06 Katholieke Universiteit Leuven Fenfluramine for use in the treatment of dravet syndrome EP3329909A1 (en) 2013-05-03 2018-06-06 Katholieke Universiteit Leuven KU Leuven Research & Development Fenfluramine for use in the treatment of dravet syndrome US12097206B2 (en) 2013-05-03 2024-09-24 Katholieke Universiteit Leuven Method for the treatment of Dravet Syndrome EP4397372A2 (en) 2015-08-24 2024-07-10 Zogenix International Limited Methods of treating lennox-gastaut syndrome using fenfluramine US11634377B2 (en) 2015-12-22 2023-04-25 Zogenix International Limited Fenfluramine compositions and methods of preparing the same US11673852B2 (en) 2015-12-22 2023-06-13 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same US11786487B2 (en) 2016-08-24 2023-10-17 Zogenix International Limited Formulation for inhibiting formation of 5-HT2B agonists and methods of using same US11759440B2 (en) 2016-08-24 2023-09-19 Zogenix International Limited Formulation for inhibiting formation of 5-HT2B agonists and methods of using same WO2018206924A1 (en) 2017-05-09 2018-11-15 Zogenix International Limited Methods of treating doose syndrome using fenfluramine WO2019067405A2 (en) 2017-09-26 2019-04-04 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation WO2019067413A1 (en) 2017-09-26 2019-04-04 Zogenix International Limited Use of fenfluramine formulation in reducing number and frequencies of convulsive seizures in patient populations WO2019067419A1 (en) 2017-09-26 2019-04-04 Zogenix International Limited Improvement in cognitive function with fenfluramine WO2020014075A1 (en) 2018-07-10 2020-01-16 Zogenix International Limited Fenfluramine for use for treating epilepsy or epileptic encephalopathy in patients without pulmonary hypertension WO2020105005A1 (en) 2018-11-19 2020-05-28 Zogenix International Limited Methods of treating rett syndrome using fenfluramine US12144787B2 (en) 2018-11-19 2024-11-19 Zogenix International Limited Method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5) WO2021053389A1 (en) 2019-09-17 2021-03-25 Zogenix International Limited Methods of treating epileptic patients with fenfluramine WO2021156437A1 (en) 2020-02-05 2021-08-12 Zogenix International Limited Fenfluramine for use in treating patients with lennox-gastaut syndrome WO2022013425A1 (en) 2020-07-17 2022-01-20 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Similar Documents Publication Publication Date Title GB1413070A (en) 1975-11-05 Process for the production of - norfenfluramine and - fenfluramine and salts thereof GB1413078A (en) 1975-11-05 Process for the production of plus-norfenfluramine and plus-fenfluramine and salts thereof GB1432576A (en) 1976-04-22 Substituted phenylacetic acids GB1425532A (en) 1976-02-18 Cyclic mercaptals and a process for the manufacture thereof GB1489778A (en) 1977-10-26 Process of preparing a stable composition containing a compound of the prostaglandin e group GB1129029A (en) 1968-10-02 Tricyclic ethylamine derivatives GB1448316A (en) 1976-09-02 Racemization of optically active 2,2-dimethyl-3,1,-alkenyl- cyclopropane-1-carboxylic acids GB1363597A (en) 1974-08-14 2-acyloxy-benzoic acid anilides process for their preparation and their insecticidal and acaricidal use GB1453906A (en) 1976-10-27 3-deoxyglucose derivatives GB1454850A (en) 1976-11-03 Process for the enzymatic isomerisation of glucose to levulose GB1428341A (en) 1976-03-17 Process for preparing 4,5-diphenyl-oxazol-2-one GB1353713A (en) 1974-05-22 Process for the preparation of squaric acid GB1444565A (en) 1976-08-04 Process for conversion of alkyl transchrysantemates in admixture with alkyl cis-chrysanthemates to the corresponding acid IL47450A (en) 1976-03-31 2,4-diamino-pyrimidine derivatives and their preparation GB1339053A (en) 1973-11-28 Method for the preparation of aromatic a-amino acids and intermediates therefor GB1169276A (en) 1969-11-05 A process for the production of Polyamides having improved Hydrophylic Properties GB1414452A (en) 1975-11-19 Process for the manufacture of cyclohexadienes GB1477499A (en) 1977-06-22 Process for the manufacture of cyclopropanecarbonitrile GB562267A (en) 1944-06-26 Process for the manufacture of a crystallised, non-hygroscopic calcium salt of d-pantothenic acid GB1515614A (en) 1978-06-28 Preparation of m-benzoylhydratropic acid and an intermediate therefor GB1421580A (en) 1976-01-21 Production of benzylamine derivatives GB1311703A (en) 1973-03-28 Carbamates their manufacture and use as pesticides GB1446701A (en) 1976-08-18 Vincamine 2-ketoglutarate and process for the production thereof GB1479731A (en) 1977-07-13 Process for the production of crystals of monosodium glutamate pentahydrate GB1317159A (en) 1973-05-16 Manufacture of cephalosporin compounds Legal Events Date Code Title Description 1976-02-25 414F Notice of opposition given (sect. 14/1949) 1978-12-06 414C Case decided by the comptroller ** grants refused (sect. 14/1949) 1979-03-07 CSNS Application of which complete specification have been accepted and published, but patent is not sealed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4